Nicotine Addiction: Clinical Trials

5 trials for Nicotine Addiction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Terminated 1

Follow Nicotine Addiction: new trials by email Literature Review of Nicotine Addiction trials Research Report on Nicotine Addiction

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Semaglutide on Nicotine Intake
Semaglutide, Sham/placebo - Tobacco Use Disorder, Nicotine Addiction
Phase 2CompletedUniversity of North Carolina, Chapel Hill242022-10-072025-08-22
Quit Smoking Study for People Who Use E-Cigarettes
Nicotine replacement therapy patch, Nicotine replacement therapy lozenge, Quit electronic cigarettes - Nicotine Addiction, E-Cig Use
Phase 2CompletedUniversity of Vermont3962021-06-272025-05-22
Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use
Smoking research cigarettes with e-cigarette, Nicotine discrimination thresholds - Nicotine Addiction, Cigarette Smoking
Phase 2CompletedRose Research Center, LLC1502019-05-012022-01-14
Effects of ABT-089 on Smoking Abstinence Symptoms and Reward
ABT-089, Placebo - Nicotine Addiction
Phase 2TerminatedUniversity of Pennsylvania172013-03-012014-10-29
Effect of Galantamine on Smoking Abstinence
Galantamine ER - Nicotine Addiction
Phase 2CompletedUniversity of Pennsylvania132012-02-012017-12-26

Narrower conditions

Tobacco Use Disorder (5)  ·  Smoking (2)  ·  Cigarette Smoking (1)  ·  Smoking Cessation (1)  ·  Vaping (1)

Broader conditions

Chemically-Induced Disorders (5)  ·  Mental Disorders (5)  ·  Substance-Related Disorders (5)  ·  Behavior (4)  ·  Smoking (2)  ·  Health Behavior (1)  ·  Tobacco Smoking (1)  ·  Tobacco Use (1)

Interventions

Electronic Nicotine Delivery Systems (1)  ·  Galantamine (1)  ·  pozanicline (1)  ·  semaglutide (1)

Sponsors

University of Pennsylvania (2)  ·  Rose Research Center, LLC (1)  ·  University of North Carolina, Chapel Hill (1)  ·  University of Vermont (1)

Countries

United States (5)

Top investigators

Caryn Lerman, PhD (1)  ·  Christian Hendershot, PhD (1)  ·  Jed E Rose, Ph.D. (1)  ·  Rebecca Ashare, Ph.D. (1)

Results publications

PMID 42189538

NIH funding

R01DA042541 (1), R21DA047663 (1)